CohBar (NASDAQ:CWBR) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the ...

TAMPA, Fla. (WFLA) – A Tampa company developing a skin cancer vaccine has recently appointed a new CEO who plans to take the company public within the next few months. Dr. James Bianco, an oncologist ...

A living organism, says the synthetic biologist, is the output generated by a tangle of interconnected subprograms. Naturally, the synthetic biologist wants to disentangle these programs and—to the ...

TAMPA, Fla. (WFLA) – Tampa company Morphogenesis has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration. Morphogenesis is a ...

(RTTNews) - CohBar, Inc. (CWBR) and Morphogenesis, Inc., a privately-held Phase 2/3 clinical-stage biotechnology company developing personalized cancer vaccines and tumor microenvironment modulators ...

A research team found that arginine metabolism has a vital role in regulating gametophore shoot formation in the moss Physcomitrium patens. Arginine metabolism boosts to make a plant body complex, ...

Tissue engineering—creating a “seed” of tissue that could grow into a functional, life-saving organ—sounds like magic. But it could become technology, thanks in part to the work led by Lance Davidson, ...